Efficacy and Safety Study of 4-Day ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT

NCT05214066 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

aGVHD
cGVHD

Interventions

DRUG: Rabbit ATG

Sponsor

Chinese PLA General Hospital